Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients.
Muto S, Takagi H, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Suzuki H.
Muto S, et al. Among authors: fukuhara m.
Anticancer Res. 2017 Jun;37(6):3169-3174. doi: 10.21873/anticanres.11676.
Anticancer Res. 2017.
PMID: 28551660